February 2008 Issue
Expecting the drug industry to police itself is unrealistic; granting FDA more power and funding to supervise clinical trials may be the answer
Six Sigma is being utilized earlier in the pharma value chain, while benchmarking and OEE are gaining ground
In a year when 'change' is the watchword in politics, even a key pharmaceutical industry trade show seems to have caught change fever. Philadelphia will surely benefit; what can attendees look forward to?
Digitizing and automating calibration has decreased downtime and improved efficiency at AstraZeneca.
Expertise in two niches - continuous manufacturing and the processing of highly active pharmaceutical ingredients - stems from the company's roots in aerospace and defense.
Should any single group have a monopoly on science-based standards?
As competitive pressures reshape pharma, career and financial planning are becoming more important than ever.
Data historians and manufacturing process intelligence platforms aim to improve manufacturing efficiency.
Pharmaceutical Manufacturings Salary and Job Satisfaction Survey reveals that the industry might be experiencing some type of a rebirth based on new ways of doing business. Efficiency, flexibility and a love for what you do are key elements to combat cost reductions and other challenges taking place.